CZ20011671A3 - Peptidová nosná skupina pro transport - Google Patents

Peptidová nosná skupina pro transport

Info

Publication number
CZ20011671A3
CZ20011671A3 CZ20011671A CZ20011671A CZ20011671A3 CZ 20011671 A3 CZ20011671 A3 CZ 20011671A3 CZ 20011671 A CZ20011671 A CZ 20011671A CZ 20011671 A CZ20011671 A CZ 20011671A CZ 20011671 A3 CZ20011671 A3 CZ 20011671A3
Authority
CZ
Czechia
Prior art keywords
transportation
support group
peptide support
peptide
truncated forms
Prior art date
Application number
CZ20011671A
Other languages
English (en)
Inventor
M. Peter Fischer
Nikolai Zhelev
Original Assignee
Cyclacel Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9825000.4A external-priority patent/GB9825000D0/en
Priority claimed from GBGB9825001.2A external-priority patent/GB9825001D0/en
Priority claimed from GBGB9902525.6A external-priority patent/GB9902525D0/en
Priority claimed from GBGB9902522.3A external-priority patent/GB9902522D0/en
Priority claimed from GBGB9914578.1A external-priority patent/GB9914578D0/en
Application filed by Cyclacel Limited filed Critical Cyclacel Limited
Publication of CZ20011671A3 publication Critical patent/CZ20011671A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43577—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
    • C07K14/43581—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies from Drosophila

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Insects & Arthropods (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Details Of Aerials (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Surgical Instruments (AREA)
  • Structure Of Belt Conveyors (AREA)
  • Medicinal Preparation (AREA)
  • Aerials With Secondary Devices (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CZ20011671A 1998-11-13 1999-11-11 Peptidová nosná skupina pro transport CZ20011671A3 (cs)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9825000.4A GB9825000D0 (en) 1998-11-13 1998-11-13 A delivery vector
GBGB9825001.2A GB9825001D0 (en) 1998-11-13 1998-11-13 A delivery vector
GBGB9902525.6A GB9902525D0 (en) 1999-02-04 1999-02-04 Translocation vectors
GBGB9902522.3A GB9902522D0 (en) 1999-02-04 1999-02-04 Truncated vectors
GBGB9914578.1A GB9914578D0 (en) 1999-06-22 1999-06-22 Truncated vetors

Publications (1)

Publication Number Publication Date
CZ20011671A3 true CZ20011671A3 (cs) 2001-10-17

Family

ID=27517480

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20011671A CZ20011671A3 (cs) 1998-11-13 1999-11-11 Peptidová nosná skupina pro transport

Country Status (13)

Country Link
US (2) US7153931B1 (cs)
EP (2) EP1135410B1 (cs)
JP (1) JP2002530059A (cs)
AT (1) ATE419273T1 (cs)
AU (1) AU766489B2 (cs)
CA (1) CA2350919A1 (cs)
CZ (1) CZ20011671A3 (cs)
DE (1) DE69940215D1 (cs)
ES (1) ES2318906T3 (cs)
GB (1) GB2346616B (cs)
HU (1) HUP0204199A3 (cs)
IL (1) IL142869A0 (cs)
WO (1) WO2000029427A2 (cs)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786397B1 (fr) * 1998-11-30 2003-01-10 Synt Em Vecteurs peptidiques de substances a travers la barriere hematoencephalique pour etre utilises dans le diagnostic ou la therapie d'une affection du snc
US6372494B1 (en) 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
US6864355B1 (en) 2000-05-02 2005-03-08 Yale University Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
US8128922B2 (en) * 1999-10-20 2012-03-06 Johns Hopkins University Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
US7049395B2 (en) 2000-05-02 2006-05-23 Yale University Anti-inflammatory compounds and uses thereof
GB0012528D0 (en) * 2000-05-23 2000-07-12 Univ Palackeho Triterpenoid derivatives
DE10027777A1 (de) * 2000-06-07 2001-12-13 Otogene Ag Transfektionsverfahren
FR2816845B1 (fr) * 2000-11-20 2006-10-20 Centre Nat Rech Scient Vecteurs de transport a travers un epithelium a jonctions serrees
JP2004534049A (ja) * 2001-06-07 2004-11-11 スキンメディカ，インコーポレーテッド 条件細胞培養培地とその用途
DE10128832A1 (de) * 2001-06-15 2003-02-06 Jochen Reis Vektor und dessen Verwendung in gentherapeutischen Verfahren
US20030083262A1 (en) * 2001-08-30 2003-05-01 Praecis Pharmaceuticals Inc. Methods and compositions for treating inflammatory disorders
AU2003207744A1 (en) * 2002-01-30 2003-09-02 Yale University Transport peptides and uses therefor
EP1354953A1 (en) * 2002-04-17 2003-10-22 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Smac-peptides as therapeutics against cancer and autoimmune diseases
EP1354952A1 (en) * 2002-04-17 2003-10-22 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Smac-peptides as therapeutics against cancer and autoimmune diseases
WO2003086470A2 (en) * 2002-04-17 2003-10-23 Deutsches Krebsforschungszentrum Smac-peptides as therapeutics against cancer and autoimmune diseases
US20060178297A1 (en) * 2003-01-28 2006-08-10 Troy Carol M Systems and methods for silencing expression of a gene in a cell and uses thereof
PT1589993E (pt) 2003-01-31 2015-03-04 Sinai School Medicine Terapia combinada para o tratamento de distúrbios de deficiência proteica
WO2004076634A2 (en) 2003-02-24 2004-09-10 Ira Sanders Cell membrane translocation of regulated snare inhibitors , compositions therefor, and methods for treatment of disease
AU2004234076A1 (en) * 2003-04-30 2004-11-11 Laboratoires Serono Sa Beta-amyloid inhibitors and use thereof
US9701725B2 (en) 2003-05-05 2017-07-11 The Johns Hopkins University Anti-cancer DNA vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
GB0311576D0 (en) * 2003-05-20 2003-06-25 Inst Of Ophthalomology Anti-inflammatory agents
WO2004112728A2 (en) 2003-06-19 2004-12-29 Mount Sinai School Of Medicine Of New York University Methods and agents for treating axonal damage, inhibition of neurotransmitter release and pain transmission, and blocking calcium influx in neurons
US7342114B2 (en) 2003-07-01 2008-03-11 California Pacific Medical Center Podophyllotoxin derivatives
EP1670497A4 (en) * 2003-09-16 2009-07-15 Garvan Inst Med Res METHODS OF IDENTIFYING C-EPSILON PROTEIN KINASE (PKC ™) MODULATORS AND METHOD FOR TREATING ABERRANT GLUCOSE METABOLISM THEREOF
US20050148534A1 (en) * 2003-09-22 2005-07-07 Castellino Angelo J. Small molecule compositions and methods for increasing drug efficiency using compositions thereof
US8067376B2 (en) 2004-11-03 2011-11-29 Forhumantech Co., Ltd. Pharmaceutical compositions for transdermal delivery
GB0803352D0 (en) 2008-02-22 2008-04-02 Ntnu Technology Transfer As Oligopeptidic compounds and uses thereof
CN101959532B (zh) * 2008-02-28 2013-02-27 东丽株式会社 经鼻给药用药物组合物
WO2009147368A1 (en) * 2008-06-04 2009-12-10 Medical Research Council Peptides
US8680263B2 (en) 2008-09-19 2014-03-25 Nektar Therapeutics Carbohydrate-based drug delivery polymers and conjugates thereof
FR2941230B1 (fr) * 2009-01-19 2011-03-18 Centre Nat Rech Scient Polypeptides d'adressage specifique a des cellules-cibles d'otx2
WO2010099401A1 (en) * 2009-02-26 2010-09-02 The Board Of Trustees Of The Leland Stanford Junior University Calcium signaling modulators involving stim and orai proteins
US8772449B2 (en) 2009-05-20 2014-07-08 Toray Industries, Inc. Cell-penetrating peptides
US20100322957A1 (en) * 2009-05-22 2010-12-23 Aderem Alan A Secretion-related bacterial proteins for nlrc4 stimulation
GB201001602D0 (en) 2010-02-01 2010-03-17 Cytovation As Oligopeptidic compounds and uses therof
JP5757497B2 (ja) * 2010-10-06 2015-07-29 公立大学法人大阪府立大学 シガトキシン類ｃｔｘ１ｂおよび５４−デオキシ−ｃｔｘ１ｂを認識するモノクローナル抗体およびそれを用いるシガトキシン類検出キット
CA2834365A1 (en) * 2011-04-28 2012-11-01 Sandia Corporation Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
EP2751128B1 (en) 2011-08-30 2021-03-03 United Kingdom Research and Innovation Cell-penetrating peptides having a central hydrophobic domain
GB201318954D0 (en) 2013-10-28 2013-12-11 Cupid Peptide Company Ltd Cell transport
GB201507722D0 (en) 2015-05-06 2015-06-17 Norwegian Univ Sci & Tech Ntnu Anti-bacterial agents and their use in therapy
CN106937529B (zh) 2015-10-27 2021-02-05 加州太平洋医疗中心 鬼臼毒素衍生物及其应用
US10087194B2 (en) 2015-10-27 2018-10-02 California Pacific Medical Center Podophyllotoxin derivatives and their use
WO2017120504A1 (en) 2016-01-08 2017-07-13 Durfee Paul N Osteotropic nanoparticles for prevention or treatment of bone metastases
US11725035B2 (en) 2016-08-09 2023-08-15 Stipe Therapeutics Aps Methods of treating a disorder associated with with insufficient stimulator of interferon genes (STING) activity
SG11201901393VA (en) * 2016-09-02 2019-03-28 Univ Illinois Kif13b-derived peptide and method of inhibiting angiogenesis
WO2018160865A1 (en) 2017-03-01 2018-09-07 Charles Jeffrey Brinker Active targeting of cells by monosized protocells
WO2018199777A1 (en) 2017-04-28 2018-11-01 Auckland Uniservices Limited Methods of treatment and novel constructs
WO2020066343A1 (ja) 2018-09-26 2020-04-02 株式会社カネカ 細胞膜透過性ペプチド
GB201915454D0 (en) 2019-10-24 2019-12-11 Norwegian Univ Sci & Tech Ntnu Antibacterial bone cement and uses thereof
GB202006699D0 (en) 2020-05-06 2020-06-17 Therapim Pty Ltd Dosage regimen
GB202008888D0 (en) 2020-06-11 2020-07-29 Norwegian Univ Of Science And Technology (Ntnu) Peptides for sepsis treatment

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847240A (en) 1978-01-16 1989-07-11 The Trustees Of Boston University Method of effecting cellular uptake of molecules
US5043329A (en) 1987-02-17 1991-08-27 Board Of Regents, University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
DE3836971C1 (cs) 1988-10-31 1990-05-17 Weck, Wolfgang, Dr.Med., 6990 Bad Mergentheim, De
FR2662698A1 (fr) 1990-06-05 1991-12-06 Centre Nat Rech Scient Nouveaux facteurs de croissance neurotropes comprenant un peptide homeoboite.
US5888762A (en) 1990-06-05 1999-03-30 Centre National De La Recherche Scientifique (Cnrs) Neurotropic growth factors comprising a homeobox peptide
EP0481930B1 (en) 1990-10-15 1997-06-18 Tecnogen S.C.P.A. Nonlinear peptides hydropathycally complementary to known amino acid sequences, process for the production and uses thereof
WO1993022343A1 (en) 1992-05-01 1993-11-11 The Rockfeller University Multiple antigen peptide system having adjuvant properties and vaccines prepared therefrom
US5674977A (en) 1993-02-05 1997-10-07 The Ontario Cancer Institute Branched synthetic peptide conjugate
US5807746A (en) * 1994-06-13 1998-09-15 Vanderbilt University Method for importing biologically active molecules into cells
FR2739621B1 (fr) 1995-10-05 1997-12-05 Centre Nat Rech Scient Peptides utilisables comme vecteurs pour l'adressage intracellulaire de molecules actives
US5843903A (en) 1995-11-27 1998-12-01 The Administrators Of The Tulane Educational Fund Targeted cytotoxic anthracycline analogs
US6344436B1 (en) * 1996-01-08 2002-02-05 Baylor College Of Medicine Lipophilic peptides for macromolecule delivery
US5877282A (en) * 1996-09-20 1999-03-02 Bristol-Myers Squibb Company Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof
EP0961619A4 (en) 1996-09-27 2001-09-26 Bristol Myers Squibb Co HYDROLYSABLE DRUGS FOR THE RELEASE OF ANTI-CANCER DRUGS IN METASTATIC CELLS
WO1998020887A1 (en) * 1996-11-14 1998-05-22 Brigham And Women's Hospital, Inc. Polyphosphoinositide binding peptides for intracellular drug delivery
US5929042A (en) 1997-03-03 1999-07-27 The Trustees Of Columbia University In The City Of New York Antisense compounds which prevent cell death and uses thereof
IT1291649B1 (it) * 1997-04-24 1999-01-19 Intercos Italiana Polveri cosmetiche rivestite con ingredienti naturali
US6635623B1 (en) * 1997-06-13 2003-10-21 Baylor College Of Medicine Lipoproteins as nucleic acid vectors
AU741546B2 (en) * 1997-07-24 2001-12-06 Perseptive Biosystems, Inc. Conjugates of transporter peptides and nucleic acid analogs, and their use
JP2001513987A (ja) * 1997-08-22 2001-09-11 ワシントン大学 誘導性制御システムおよびその使用
GB9718609D0 (en) * 1997-09-02 1997-11-05 Imp College Innovations Ltd Fusion protein
EP1068338A2 (en) * 1998-03-06 2001-01-17 Oxford Biomedica (UK) Limited Enhanced prodrug activation
WO1999064449A2 (en) * 1998-06-10 1999-12-16 The Queen's University Of Belfast Cell-permeable peptide
GB9812675D0 (en) 1998-06-11 1998-08-12 Univ Edinburgh Peptides
GB9814527D0 (en) * 1998-07-03 1998-09-02 Cyclacel Ltd Delivery system

Also Published As

Publication number Publication date
EP1958961A2 (en) 2008-08-20
JP2002530059A (ja) 2002-09-17
EP1958961A3 (en) 2008-09-03
GB2346616A (en) 2000-08-16
HUP0204199A2 (hu) 2003-03-28
GB9926719D0 (en) 2000-01-12
AU1063000A (en) 2000-06-05
WO2000029427A2 (en) 2000-05-25
ATE419273T1 (de) 2009-01-15
HUP0204199A3 (en) 2005-09-28
US7101967B2 (en) 2006-09-05
WO2000029427A3 (en) 2000-10-05
US7153931B1 (en) 2006-12-26
US20020098236A1 (en) 2002-07-25
ES2318906T3 (es) 2009-05-01
AU766489B2 (en) 2003-10-16
EP1135410A2 (en) 2001-09-26
IL142869A0 (en) 2002-03-10
CA2350919A1 (en) 2000-05-25
GB2346616B (en) 2004-04-21
DE69940215D1 (de) 2009-02-12
EP1135410B1 (en) 2008-12-31

Similar Documents

Publication Publication Date Title
CZ20011671A3 (cs) Peptidová nosná skupina pro transport
IL128829A0 (en) Improved solid-phase peptide and agent for use in such synthesis
TR199900666T2 (xx) �nsan paratormonu ile ilgili peptidlere kar�� antikor.
ATE368053T1 (de) Antimikrobielle peptide
ATE460429T1 (de) Polypeptide enthaltend extrazellulären domäne von il-20ra und/oderr il-20rb
ATE368688T1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
HK1021824A1 (en) Compositions and methods for treating infections using analogues of indolicidin
IL113617A0 (en) Soluble polypeptide fraction
PT1144607E (pt) Novos métodos para apresentar (poli)peptídeos/ proteínas em partículas bacteriofágicas através de ligações dissulfureto
BR0205983A (pt) fármacos peptìdicos antiangiogênicos
CY1110381T1 (el) Πεπτιδια χ-κωνοτοξινης ως αναστολεις των νευρωνικων αμινικων μεταφορεων
NO960939D0 (no) Kininogenaseinhibitor
GB9606040D0 (en) Active peptide
EP0820295A4 (en) MODIFIED ARGININE OR LYSINE CONTAINING PROTEINS AND PEPTIDES
IL115381A (en) Polypeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone
AU3223297A (en) Glycine transporter-transfected cells and uses thereof
ATE314474T1 (de) Klonering von dem gen für das t gondii protein gp 28.5 peptidfragmente aus diesem protein und ihre verwendungen.
EP1140131A4 (en) PEPTIDES AND PEPTID ANALOGS, DERIVED FROM HFE PROTEIN, AND THEIR USE IN THE TREATMENT OF DISEASES, WHICH ARE FROM OVER IRON
ATE315646T1 (de) Leukocyten-aktivierender faktor
CA2254835A1 (en) Glycine transporter-transfected cells and uses thereof